CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company’s annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann
CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company’s annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann